Rabeprazole sodium
Rabeprazole sodium is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Rabeprazole sodium; Generic name: RABEPRAZOLE SODIUM; Manufacturer: Preferred Pharmaceuticals Inc..
| Brand name | Rabeprazole sodium |
|---|---|
| Generic name | RABEPRAZOLE SODIUM |
| Manufacturer | Preferred Pharmaceuticals Inc. |
| Used for | 1 INDICATIONS AND USAGE Rabeprazole sodium delayed-release tablets is a proton pump inhibitor (PPI) indicated in adults for: • Healing of Erosive or Ulcerative Gastroesophageal Reflux Disease (GERD) ( 1.1 ). • Maintenance of Healing of Erosive or Ulcerative GERD ( 1.2 ). • Treatment of Symptomatic GERD ( 1.3 ). • Healing of Duodenal Ulcers ( 1.4 ). • Helicobacter pylori Eradication to Reduce Risk of Duodenal Ulcer Recurrence ( 1.5 ). • Treatment of Pathological Hypersecretory Conditions, Including Zollinger-Ellison Syndrome ( 1.6 ). In adolescent patients 12 years of age and older for: • Short-term Treatment of Symptomatic GERD ( 1.7 ). 1.1 Healing of Erosive or Ulcerative GERD in Adults Rab |
| Dosage | 2 DOSAGE AND ADMINISTRATION Indication Recommended Dosage ( 2 ) Healing of Erosive or Ulcerative Gastroesophageal Reflux Disease (GERD) 20 mg once daily for 4 to 8 weeks Maintenance of Healing of Erosive or Ulcerative GERD* studied for 12 months 20 mg once daily* Symptomatic GERD in Adults 20 mg once daily for 4 weeks Healing of Duodenal Ulcers 20 mg once daily after morning meal for up to 4 weeks Helicobacter pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence Three Drug Regimen: |
| Active ingredient(s) | RABEPRAZOLE SODIUM |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1855ccab-c377-4962-9225-3c5adc62e2bd |